• Publications
  • Influence
Early Left Ventricular Function Abnormalities in Obstructive Sleep Apnea
TLDR
Tissue Doppler Imaging might be a reliable method for detection of early abnormalities in LV function in patients with OSA, even without overt diastolic or systolic LV dysfunction. Expand
Lipid-Lowering Potency and Tolerability of Generic Rosuvastatin in Bulgarian Patients with High and Very High Risk
TLDR
The generic rosuvastatin ROSWERA® at dosage 10 mg and 20 mg daily demonstrated high lipidlowering efficacy and good safety profile in patients at high and very high cardiovascular risk. Expand
Risk Factors, Co-Morbidities and Treatment of In-Hospital Patients with Atrial Fibrillation in Bulgaria
TLDR
Reduced and mid-range left ventricular ejection fraction, valvular heart disease, and HTN were the risk factors with the strongest association with AF and a large number of AF patients were administered antithrombotic treatment, which should be further improved. Expand
IMPACT OF SOME MODIFIABLE CARDIOVASCULAR RISK FACTORS ON THE EARLY PROGNOSIS AFTER ACUTE MYOCARDIAL INFARCTION
Cardiovascular diseases (CVD) remain the main cause of death in most parts of the world 47% of all deaths in Europe are due to CVD. In addition to being the largest contributor to mortality inExpand
Effects of Aliskiren on Blood Pressure and Myocardial Function Assessed by Global Longitudinal Strain in Patients with Arterial Hypertension and Diastolic Dysfunction
TLDR
Adding aliskiren to combined antihypertensive therapy leads to significant improvement of hypertension control and myocardial function assessed by global longitudinal strain. Expand
Assessment of lipid-lowering treatment in Bulgaria — The CEPHEUS study
TLDR
A multicenter cross-sectional survey of 2,500 Bulgarian adult patients taking lipid-lowering drugs (LLDs) for at least 3 months with no dose change for a minimum of 6 weeks established the proportion of patients who are on LDL-C target, according to the Fourth Joint European Task Force guidelines. Expand
Effects of the angiotensin receptor blocker Valsartan (Valsacor®) on arterial pressure, indices of myocardial diastolic function and global longitudinal strain in patients with uncontrolled arterial
TLDR
Valsartan (Valsacor®), used as an adjunct to the standard antihypertensive therapy in patients with insufficiently controlled AH, leads to optimisation of the AP values and improvement of the indices of diastolic and global myocardial function, with a very good safety profile. Expand
...
1
2
3
4
...